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Peripheral nerve injury increases glutamateevoked calcium mobilization in adult spinal
cord neurons
Suzanne Doolen, Camille B Blake, Bret N Smith and Bradley K Taylor*

Abstract
Background: Central sensitization in the spinal cord requires glutamate receptor activation and intracellular Ca2+
mobilization. We used Fura-2 AM bulk loading of mouse slices together with wide-field Ca2+ imaging to measure
glutamate-evoked increases in extracellular Ca2+ to test the hypotheses that: 1. Exogenous application of glutamate
causes Ca2+ mobilization in a preponderance of dorsal horn neurons within spinal cord slices taken from adult
mice; 2. Glutamate-evoked Ca2+ mobilization is associated with spontaneous and/or evoked action potentials;
3. Glutamate acts at glutamate receptor subtypes to evoked Ca2+ transients; and 4. The magnitude of glutamateevoked Ca2+ responses increases in the setting of peripheral neuropathic pain.
Results: Bath-applied glutamate robustly increased [Ca2+]i in 14.4 ± 2.6 cells per dorsal horn within a 440 x 330 um
field-of-view, with an average time-to-peak of 27 s and decay of 112 s. Repeated application produced sequential
responses of similar magnitude, indicating the absence of sensitization, desensitization or tachyphylaxis. Ca2+
transients were glutamate concentration-dependent with a Kd = 0.64 mM. Ca2+ responses predominantly occurred
on neurons since: 1) Over 95% of glutamate-responsive cells did not label with the astrocyte marker, SR-101; 2) 62%
of fura-2 AM loaded cells exhibited spontaneous action potentials; 3) 75% of cells that responded to locally-applied
glutamate with a rise in [Ca2+]i also showed a significant increase in AP frequency upon a subsequent glutamate
exposure; 4) In experiments using simultaneous on-cell recordings and Ca2+ imaging, glutamate elicited a Ca2+
response and an increase in AP frequency. AMPA/kainate (CNQX)- and AMPA (GYKI 52466)-selective receptor
antagonists significantly attenuated glutamate-evoked increases in [Ca2+]i, while NMDA (AP-5), kainate (UBP-301)
and class I mGluRs (AIDA) did not. Compared to sham controls, peripheral nerve injury significantly decreased
mechanical paw withdrawal threshold and increased glutamate-evoked Ca2+ signals.
Conclusions: Bulk-loading fura-2 AM into spinal cord slices is a successful means for determining glutamate-evoked
Ca2+ mobilization in naïve adult dorsal horn neurons. AMPA receptors mediate the majority of these responses.
Peripheral neuropathic injury potentiates Ca2+ signaling in dorsal horn.
Keywords: Pain, AMPA receptor, Central sensitization, Calcium imaging

Background
Central sensitization is a glutamate receptor-dependent
increase in the excitability of neurons within the central
nervous system, and is thought to contribute to
enhanced responsiveness to sensory input following tissue injury [1]. After nerve injury, damaged and nondamaged peripheral afferents generate spontaneous
* Correspondence: brad.taylor@uky.edu
Department of Physiology, School of Medicine, University of Kentucky
Medical Center, Lexington, KY 40536, USA

action potentials (AP) within nociresponsive neurons
within the dorsal horn [2]. Glutamate, released from
pre-synaptic terminals in an activity-dependent manner,
binds post-synaptic ionotropic and metabotropic receptors, leading to intracellular Ca2+ mobilization [1,3,4].
The resulting calcium-induced activation of intracellular
kinases can then phosphorylate several residues on the
C-terminus of NMDA and AMPA receptors; these posttranslational modifications, together with increased receptor trafficking to and from the membrane and
increased responsiveness to glutamate, are thought to
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contribute to the functional changes that manifest as
central sensitization [5-7]. Despite the importance of
Ca2+ mobilization to the central sensitization that drive
neuropathic pain, however, few studies have investigated
real-time [Ca2+]i responses in populations of dorsal horn
neurons [8,9].
While patch-clamp recording allows sampling of single
neurons, the bulk-loading of Ca2+-sensitive indicator
dyes enables simultaneous recording across populations
of dorsal horn cells. However, previous studies describing bulk-loaded Ca2+ imaging in spinal cord slices have
not fully discriminated between neuronal and glial
responses [8-10]. One obstacle is that both neurons and
astrocytes exhibit glutamate-evoked Ca2+mobilization in
the CNS [11,12]. To overcome this obstacle in our spinal
cord slice imaging studies, we employed the fluorescent
dye SR-101, a specific marker of astroglia in the CNS
[13,14].
Behavioral pharmacology studies support the contribution of spinal glutamatergic and Ca2+ channel signaling to the development and/or maintenance of
allodynia and hyperalgesia [15-18]. For example, it is
well-known that intrathecal AMPA- and NMDAreceptor antagonist administration attenuates pain-like
behavior in models of neuropathic pain [15-19]. Furthermore, convergent observations obtained in a variety
of pain models indicate that intrathecal administration
of antagonists to N- and T-type voltage-gated calcium
channels (VGCC) produce anti-allodynic effects, with
smaller effects after injection of P/Q- and L-type channel blockers [20-26]. While these studies implicate glutamate receptors and Ca2+ signaling in central
sensitization and neuropathic pain, the underlying cellular mechanisms are poorly understood. In this study, we
show that glutamate-evoked Ca2+ signals in adult dorsal
horn neurons are mediated predominantly by AMPA
channels and are potentiated by peripheral neuropathic
injury.

Results
Glutamate-evoked Ca2+ mobilization in adult dorsal horn
neurons

To determine whether exogenous application of glutamate causes Ca2+ mobilization in a preponderance of
lamina II dorsal horn cells of adult mice, we conducted
Fura-2 Ca2+ imaging within transverse spinal cord
slices. Spontaneous calcium waves were not observed,
consistent with previous reports in 11–15 day-old mice
[10]. Within a 440 x 330 um field-of-view in 9 dorsal
horn slices, we observed an average of 15 ± 1 Fura-2
loaded cells. Imaged cells were located less than 35 um
below the tissue surface. Glutamate superfusion (1 mM,
10 s) evoked Ca2+ transients in 93% (14 ± 2) cells
(Figure 1 and Table 1). Glutamate increased [Ca2+]i with
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an average time-to-peak and duration (from onset to
return to 20% of peak) of approximately 27 s and 139 s,
respectively.
Both CNS neurons and astrocytes respond to glutamate with intracellular Ca2+ mobilization [11,12]. To
discriminate the two cell types, we used real-time
double-labeling with fura-2 and SR-101. Previous studies
indicate that incubation of brain slices with SR-101
specifically labels astrocytes for at least 8 h [13,14]. As
illustrated in Figure 1 and Table 1, SR-101 labeled
16 ± 1.8 cells within a 440 x 330 um field-of-view in the
dorsal horn (n = 9 views). Of the 130 glutamateresponsive cells, 4 ± 1.4% (6 cells) were labeled with SR101. Of the SR-101 positive cells, only a small proportion, 4 ± 1.7%, were glutamate responsive. These data
suggest that the vast majority of glutamate-responsive
cells are SR-101 negative, and thus likely represent nonastrocytic cells.
To further test the hypothesis that glutamate-evoked
Ca2+ responses in spinal cord slices occur primarily
in neurons, we conducted experiments to concurrently
assess Ca2+ mobilization and electrophysiological responses
to glutamate. We evaluated whole-cell recordings in 29
fura-2 loaded cells. Spontaneous APs were observed in
18 neurons (62.1%), with an average firing frequency of
2.97 ± 0.63 Hz. We found 20 cells that responded to a
brief pulse of glutamate with a [Ca2+]i increase (at least
10% above baseline). Of these, 15 (75%) exhibited a
significant increase in AP frequency upon a subsequent
glutamate exposure (from 3.0 ± 6 Hz in ACSF to
29.0 ± 8.7 Hz after glutamate, p < 0.01, n = 15; paired
t-test). Figure 2A shows that glutamate caused a transient increase in AP firing.
On-cell recording allows for simultaneous electrophysiological recording and Ca2+ imaging because it
employs a GΩ seal without rupturing the cell and
allowing intracellular fura-2 to diffuse into the recording pipette. As illustrated in Figure 2B, experiments
using simultaneous on-cell recordings and Ca2+ imaging, Ca2+ responses to glutamate were accompanied
an increase in AP frequency. For both whole-cell and
on-cell recordings, glutamate-evoked AP burst after
focal glutamate application onset was rapid
(2.54 ± 1.0 s), corresponding temporally with the Ca2+
rise. Action potential bursts (1.02 ± 0.38 s; n = 15) were
typically of shorter duration than the corresponding
Ca2+ response (34.03 ± 10.26 s) (Figure 3). To further
characterize [Ca2+]i responses, we administered glutamate repeatedly and at varying concentrations. As illustrated in Figure 3A, repeated superfusion with
glutamate (1 mM for 10 s at 10 min intervals)
produced sequential responses of similar magnitude
(F(5,18) = 0.43, p = 0.82), indicating the absence of
sensitization, desensitization or tachyphylaxis.
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Figure 1 Calcium imaging in adult mouse spinal cord slices. Ratiometric images of dorsal horn before (A) and during (B) a 10 s exposure to
1 mM glutamate. Pseudocolor images show values of the 340/380 ratio where blue indicates basal Ca2+ levels and green/red indicate a
glutamate-evoked Ca2+ increase. C. Glutamate-evoked Ca2+ traces evoked in panels A and B. The red trace represents an SR-101 positive cell
indicated by the red arrowhead in A and B and the green traces represent SR-101 negative cells indicated by green arrows. Numbers on green
arrows correspond to numbered traces in panel C. D. Numerous cells bulk loaded with Fura-2 AM are indicated by white arrowheads. A doublelabeled astrocytic cell is indicated by a red arrowhead. E. Astrocyte labeling pattern with SR-101 in the same adult spinal cord slice. F. Merged
image shows that the majority (~95%) of Fura-2 AM loaded cells are non-astrocytic.

Glutamate receptor pharmacology

AMPAR, NMDAR and kainate receptor (KAR), as well
as metabotropic (mGluRs, groups I–III) glutamate
receptors are densely expressed in the dorsal horn and
contribute to the initiation and maintenance of central
sensitization [1,3,27-37].To confirm that glutamate acted
through a receptor-dependent mechanism, we first evaluated [Ca2+]i responses to increasing glutamate concentrations. As illustrated in Figure 3B, the magnitude of
glutamate-evoked increases in [Ca2+]i was concentration–dependent, with an ED50 = 0.64 mM.
To investigate which ionotropic receptor subtype(s)
contribute to glutamate-evoked Ca2+ responses, spinal
cord slices were pre-incubated with selective receptor

antagonists. The repeatability of glutamate responses
allowed for a simple, within-subject design involving
glutamate application followed by antagonist administration prior to and during a second glutamate application. Ca2+ transients in response to glutamate in the
presence of increasing concentrations of the AMPA/
kainate receptor antagonist CNQX are shown in
Figure 4A. CNQX attenuated glutamate-evoked Ca2+
transients in a concentration-dependent manner with an
IC50 = 6.5 μM. The highest concentration tested
(200 μM) produced an 83.1 ± 2.9% reduction (Figure 4B;
F(4,13) = 8.33, p < 0.01). Similarly, GYKI 52466, a selective
AMPA receptor antagonists, attenuated glutamateevoked Ca2+ transients with an IC50 = 6.1 μM. The

Table 1 SR-101 labeling and action potentials in cells that respond to glutamate with an increase in [Ca2+]i
# cells exhibiting glutamate-evoked increase [Ca2+]i

SR-101 positive cells

Double labeled cells

% Double labeled cells

130 (14 ± 2.6)

149 (16 ± 1.8)

6 (1 ±0.23)

4.36 ± 1.4

# cells exhibiting glutamate-evoked increase [Ca2+]i

# cells exhibiting Spontaneous AP

%

29

18

62.1

20

# cells exhibiting glutamate-evoked AP

%

15

75

Data represent total cell counts. Average ± SEM per slice shown in parenthesis are from 9 slices from 9 different animals.
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Figure 2 Glutamate-evoked Ca2+ response and APs in DH neurons. A. Electrophysiological responses to glutamate are also repeatable.
Whole cell recording from slices prepared from a post-natal day 13 mouse shows current responses to glutamate (50 mM; 200 ms). B. Ca2+
response to glutamate (50 mM; 50 ms pulse). Inset: Fluorescent images taken with excitation at 340 nm before (left) and during exposure to
glutamate (right). Scale bar: 10 um. C. Simultaneous on-cell recording indicates glutamate-evoked AP currents concurrently with Ca2+ response.
Inset: Left: AP frequency over time. Right: Enlarged view showing generation of AP currents. *** P < 0.0001.

maximal effect of GYKI 52466 observed at 100 μM was
56.7% (Figure 4C; F(4,30) = 4.25, p < 0.01). By contrast, the
kainate-selective antagonist UBP-301 did not significantly attenuate glutamate-evoked Ca2+ responses
(Figure 4D; F(2, 18) = 0.89, p = 0.42). Neither did UBP-310,
another selective kainate antagonist (p > 0.05, data not
shown). AP-5, an NMDA-selective antagonist, also did
not change glutamate-evoked Ca2+ responses (Figure 4E;
F(4, 26) = 1.78, p = 0.34).

In addition to evoking Ca2+ influx through ionotropic
glutamate receptors, glutamate can activate group I
metabotropic receptors. Group I mGluRs couple to
Gq/11 [38] and mobilize Ca2+ release from intracellular
stores while group II and III couple to Gi/o. Although
group I receptors do not participate in basal nociception, their activation is necessary for activity-dependent
central sensitization [39-44]. As illustrated in
Figure 4F, however, the group I metabotropic
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Figure 3 Calcium responses elicited by glutamate. (A.-B.) Average peak Ca2+ responses are repeatable and concentration dependent. Slices
prepared from 4–6 wk CD-1 mice were superfused with aCSF at 1 ml/min. Scale bar: horizontal, Δ340/380 = 0.1; vertical, time = 60 s. Data
represent average ± SEM. A. Representative tracings and average peak Ca2+ responses to 10-s pulses of 1 mM glutamate spaced at 10 min
intervals. Glutamate elicited repeatable [Ca2+]i transients. N = 4 slices. B. Representative tracings and average peak Ca2+ responses to increasing
glutamate concentrations. N = 3 slices.

glutamate receptor antagonist AIDA (up to 500 μM)
did not significantly change Ca2+ responses as
compared to vehicle (F(3,15) = 2.14, p = 0.13).
Glutamate-evoked Ca2+ mobilization in neuropathic injury

Behavioral pharmacology studies support the contribution of glutamatergic and Ca2+ channel signaling to the
development and/or maintenance of neuropathic pain
[15-19]. To test the hypothesis that peripheral nerve injury potentiates glutamate-evoked Ca2+ responses in a
manner that coincides with neuropathic pain-like behavior, we first evaluated tactile sensitivity prior to, 1d, 3d
and 7d following Sham or SNI surgery. Figure 5A illustrates the development of mechanical hyperalgesia at
7 days post-SNI surgery. The force required to elicit
hindpaw withdrawal decreased from a pre-surgical mean
baseline value of 3.5 ± 1.1 to a much lower value on day
7 after SNI of 0.1 ± 0.04. Thus, compared to sham controls, SNI significantly reduced hindpaw withdrawal
threshold (F(2,40) =4.66, p < 0.05). We next evaluated
the glutamate dose-response relationship of peak Ca2+
signals in slices obtained 7–10 days after surgery,
(Figure 5B). Compared to Sham, SNI produced
significantly greater glutamate-evoked Ca2+ signals
(F(1,11) = 9.8, p < 0.05). Bonferroni post-hoc analysis
found this difference to be significant at all concentrations above 0.03 mM.

Discussion
The present study characterizes glutamate-evoked Ca2+
mobilization in adult dorsal horn and its modulation by
neuropathic injury. For the first time, we report simultaneous Ca2+ imaging of multiple neurons in adult
mouse spinal cord slices using real-time imaging of
Fura-2 and SR 101. Our results reflect an assay in which

glutamate predominantly evokes Ca2+ signals in neurons, and indicated that this is largely mediated by
AMPA receptors. Our results indicate that SNI potentiates Ca2+ signaling and may lead to spinal cord central
sensitization and neuropathic pain.
Glutamate superfusion evokes repeatable, concentrationdependent Ca2+ mobilization in the dorsal horn of adult
spinal cord slices

In vitro spinal cord slice studies of pain transmission
most commonly use tissues obtained from neonatal
rodents [10,45,46]. Since AMPA subunit mRNA levels
[47] and both NMDA and AMPA receptor subunit protein expression in the spinal cord are high during development and decline until 4 weeks of age [48] plasticity
in response to neuropathic or inflammatory insult is not
clear. We chose to study the mechanisms responsible for
Ca2+ signaling in adults because glutamate signaling in
rodents is not mature until 4 wk of age [47-53]. It is also
important to characterize Ca2+ mobilization in adult
spinal cord since many animals models of pain take
many weeks to establish.
A previous Ca2+ imaging study in transverse slices
from adult spinal cord indicated that imaging was unsatisfactory in slices from animals older than 15 days
[10,54], perhaps due to poor fura-2 uptake into the tissue. However, with the use of ice cold transcardial perfusion with aCSF containing kynurinic acid, rapid spinal
cord isolation, and a slicer with minimal advance speed
and minimal blade deflection, we were able to elicit
glutamate-evoked [Ca2+]i increases in nearly all fura-2
loaded cells from young adult animals. Furthermore, the
magnitude of [Ca2+]i responses was concentrationdependent, and sustained with repeated applications of
glutamate. These results indicate superb tissue health of

Doolen et al. Molecular Pain 2012, 8:56
http://www.molecularpain.com/content/8/1/56

Page 6 of 12

Figure 4 Effect of sub-type selective antagonists on glutamate-evoked Ca2+ responses. Slices prepared from 4–6 wk CD-1 mice were
superfused with aCSF at 1 ml/min. A. Representative Ca2+ traces from dorsal horn cell in response to 1 mM glutamate in the presence of
increasing concentrations of CNQX. The last trace is after a final washout, indicating that the tissue is still viable and responsive to glutamate. B,
CNQX (3–6 slices); C, GYKI 52466 (4–14 slices); D, UBP-301 (3 slices); E, AP-5 (4–11 slices); F, AIDA, (3–8 slices). Antagonists were present for 10 min
prior, as well as during glutamate-evoked stimulation. Data represent average ± SEM. *P < 0.05.

our slice preparation, and demonstrate access of the cells
to the superfusion fluid.
Glutamate concomitantly evoked APs and robust
increases in [Ca2+]i. The Ca2+ response peaked at approximately 30 sec and typically lasted 2–3 minutes,
consistent with the temporal profile of [Ca2+]i increase
following NMDA superfusion in Fura-2-injected single
cells of 18–30 d old spinal cord slices [55]. By contrast,
the duration of neuronal firing during the glutamate puff
application lasted about 1 second. This most likely
resulted from inactivation of Na+-dependent APs caused
by the continued and strong depolarization of the neurons by glutamate. Our whole-cell voltage tracings suggest that the glutamate-dependent depolarization

persisted even after sodium channels were inactivated.
This sustained depolarization may reflect or contribute
to the substantial Ca2+ mobilization following glutamate
stimulation, which takes several minutes to return to
basal [Ca2+]i levels. Further experiments will be necessary to determine the relative contribution of APs and
VGCC opening, Ca2+ entry through glutamate receptors,
or intracellular Ca2+ release from stores to the
glutamate-evoked [Ca2+]i rise.
Glutamate-evoked Ca2+ mobilization occurs
predominantly in neurons

Sandkuhler and colleagues were the first to describe
Ca2+ responses in adult transverse spinal cord slices

Doolen et al. Molecular Pain 2012, 8:56
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predominantly in neurons. First, we found that less
than 5% of glutamate-responsive cells were labeled
with the astrocyte marker, SR-101. This is consistent
with recent in vivo studies from the hindlimb area of
the mouse primary somatosensory cortex, which
demonstrated that ~5% of SR-101 labeled astrocytes
exhibit Ca2+ transients in response to mechanical hindlimb stimulation [57]. On the other hand, ~80% of
SR101 cells were stained with fluo-4 AM in juvenile
hippocampal slices from rats [58]. Different cell types
in CNS tissue slices acquire Ca2+-sensitive dyes with
different efficiency, presumably as a result of variability
in cellular surface-to-volume ratio [59]. We speculate
that, in our spinal cord slice preparation, fura-2 is particularly facile at crossing the neuronal membrane.
A second piece of evidence indicating that Ca2+
responses predominantly occur on neurons is our electrophysiological data, which suggests that the majority of
fura-2 loaded cells are excitable. For example, 62% of
fura-2 loaded cells exhibited spontaneous APs and 75%
of cells that responded to glutamate with a rise in
[Ca2+]i also showed a significant increase in AP frequency upon a subsequent glutamate exposure. In
experiments using simultaneous AP recordings and
Ca2+ imaging, glutamate elicited a Ca2+ response and
an increase in AP frequency. We conclude that, since
the majority of glutamate-responsive fura-2 loaded cells
are non-astrocytic and are electrically excitable, neurons make up the majority of responsive cells.

Figure 5 Effect on peripheral nerve injury on glutamate-evoked
Ca2+ transients. A. Development of mechanical hyperalgesia
following SNI. Withdrawal threshold of the ipsilateral hindpaws to
mechanical stimulation with von Frey hairs in SNI mice are
compared to those of sham-operated mice. B. Peak glutamateevoked Ca2+ responses in dorsal horn slices from sham and
neuropathic (SNI) mice. Slices were prepared from 5 wk mice 7–10 d
after sham or SNI surgery. Ca2+ responses were evoked by a 10 s
exposure to glutamate at concentrations indicated. Data represent
average ± SEM from 5 slices. *P < 0.05.

pre-loaded with fura-2 [8]. Both neurons and astrocytes exhibit glutamate-evoked calcium mobilization in
the CNS [11,12,56]. Sandkuhler and colleagues defined
a Ca2+ response to be neuronal if it peaked within 1 s
of stimulus initiation, and its amplitude exceeded ten
times baseline noise [8]. They also stated that patchclamp recordings from fura-2-loaded dorsal horn cells
suggested responses to be neuronal; however, they did
not present data confirming this finding [8]. Because
more recent studies indicate that mechanical sensory
stimulation can elicit Ca2+ transient peaks in astrocytes
within 0.5 s [57], we sought more direct evidence indicating that Ca2+ responses to glutamate occur

Glutamate-evoked Ca2+ mobilization is predominantly
driven by AMPA receptor activation

The AMPA/kainite and AMPA receptor-selective
antagonists CNQX and GYKI 52466 substantially inhibited glutamate-evoked increases in [Ca2+]i, while
kainate-, NMDA-, and metabotropic class I- selective
antagonists did not. These data suggest that in dorsal
horn of adult mice, AMPA receptors are sufficient to
drive glutamate-evoked Ca2+ signaling, either directly or
by eliciting APs, which activate VGCCs. This is not surprising because at resting conditions the NMDA receptor channel pore is blocked by Mg2+ [60]. This contrasts
with results obtained in spinal cord slices from juvenile
mice where both NMDA and AMPA receptors contribute to Ca2+ mobilization in response to dorsal root
stimulation [10]. One explanation for these disparate
findings is that, relative to neonate, adult NMDA receptors play a relatively small role in glutamate-evoked Ca2+
mobilization. More specifically, NR2B mRNA is present
in lamina II during embryonic development through
adulthood [61]. The NR2B subunit is characterized by a
relatively strong Mg2+ block [52], and therefore AMPA
contribution may not be sufficient to relieve the Mg2+
block from NMDA receptors in adult slices. Conversely,
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the NR2D subunits that are highly expressed in dorsal
horn at P1 and P7 (but absent by P14) [61], are characterized by a relatively weak Mg2+ block [52], and therefore AMPA contribution would be sufficient to relieve
the Mg2+ block from NMDA receptors in juvenile slices.
A second possible explanation is that the dorsal root
stimulation used in the juvenile slice studies provides
synaptically localized glutamate release that is sufficient
to activate NMDA receptors, whereas our concentrations of superfused glutamate do not reach sufficiently
high concentrations to elicit NMDA receptor activation.
Indeed, we found that the AP-5 produced a trend towards inhibition of glutamate-evoked Ca2+ response,
which is similar to the small 20% decrease observed in
the setting of dorsal root stimulation [55].
Possible mechanisms by which the AMPA receptor
contributes to glutamate-evoked Ca2+ mobilization include depolarization-induced expulsion of the NMDA
Mg2+ block, thus allowing Ca2+ entry through the
NMDA receptor [62]. Alternatively, Ca2+ may enter the
pore of calcium-permeable AMPA receptors. Agonistinduced cobalt-uptake, a surrogate marker for agonistinduced calcium influx, has revealed a high density of
Ca2+-permeable AMPA receptors in the spinal dorsal
horn, particularly in superficial laminae [63]. Activation
of AMPA receptors can also induce APs. Since glutamate most often resulted in AP generation in dorsal horn
neurons, the depolarization, consequent opening of
VGCCs, and subsequent Ca2+ flux is a likely contributor
to the Ca2+ mobilization we observed.
Our findings that class I mGlu receptors do not contribute to Ca2+ mobilization is in agreement with previous studies [10]. Previous studies also support our
finding that kainate receptors do not contribute to Ca2+
mobilization: although kainate receptors on DRG neurons are predominantly Ca2+-permeable in late
embryonic and newborn rats, they become fully
Ca2+-impermeable later in the first postnatal week [34].
While these data suggest that kainate and class I mGlu
receptors do not contribute to Ca2+ mobilization in
naïve animals, they do not rule out the possibility that
they contribute to central sensitization after nerve injury
[39-44,64].
Neuropathic injury potentiates glutamate-evoked Ca2+
mobilization

Our studies demonstrate that nerve injury produced
mechanical hypersensitivity and potentiated glutamateevoked Ca2+ mobilization in adult dorsal horn neurons.
These data are consistent with behavioral pharmacology
studies supporting the contribution of glutamatergic and
Ca2+ channel signaling to the development and/or maintenance of neuropathic pain [15-18]. By what mechanism does SNI potentiate glutamate evoked increases in
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[Ca2+]i? We present several possibilities. 1) One possible
mechanism is that injury-induced afferent activity might
drive the entry of Ca2+ through NMDA channels. After
peripheral nerve injury, damaged and uninjured A- and
C-fibers begin to generate spontaneous APs, leading to
the release of primary afferent neurotransmitters [2].
Slow depolarization induced by peptides such as substance P may then lead to expulsion of Mg2+ block,
allowing for NMDA channel opening and Ca2+ entry
upon glutamate stimulation [65]. 2) A second possible
explanation is that injury-induced activation of kinases
may lead to the phosphorylation and subsequent alteration of NMDA and/or AMPA receptors. For example,
upon noxious stimulation, PKA phosphorylates GluR1
subunits, causing insertion of these receptors into the
post-synaptic membrane, thus leading to an increase in
synaptic strength [31,66,67]. Also, noxious stimuli cause
phosphorylation of NMDA NR1 subunits by PKA or
PKC, leading to enhanced response to glutamate. [6871]. 3) A third mechanism is that SNI increases mGluR
activation of Gq/11 thus leading to increased Ca2+
mobilization. Peripheral inflammation causes trafficking
of group I mGluRs to the plasma membrane in the
spinal dorsal horn neurons [36] and behavioral studies
indicates a greater response to group I mGluR agonists
in CCI compared to control, suggesting that group I
mGluRs contribute to neuropathic pain [72]. 4) A fourth
possible mechanism is that SNI induced a switch from
GluR2-containing to GluR2-lacking AMPARs; this
would allow for increased Ca2+ entry through the AMPA
receptor pore. Ca2+ permeability is modified not only by
neuronal activity, but also by changes in expression, trafficking post-translation changes of AMPAR subunits
[73,74]. Studies using inflammatory pain models indicate
activity-dependant GluR1 expression on the cell membrane and GluR2 internalization [75,76]. 5) A fifth possible mechanism is that astrocytic Ca2+ elevations
induce NMDA receptor-mediated slow inward currents
(SICs) and Ca2+ elevations in neurons, leading to pain
sensitization. Experimentally induced stimuli that trigger
Ca2+ mobilization in astrocytes (low Ca2+, BzATP) induce NMDA receptor-mediated SICs in neurons in the
rat dorsal horn, and these SICs are significantly
increased by inflammatory injury [77]. Our finding that
glutamate induces Ca2+ elevations in a subset of astrocytes support the presence of this mechanism in dorsal
horn. 6) A sixth, more general mechanism is that injury
increases the electrophysiological properties of the postsynaptic neurons. While chronic sciatic constriction in
rat did not change resting membrane potential, response
threshold, or input resistance, it did increase the amplitude and frequency of subthreshold synaptic currents in
a subset of lamina II neurons [78]. Ultimately, one or
more likely several of these mechanisms could increase
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neuronal Ca2+ mobilization, a critical step to central
sensitization.

Methods
Animals

Adult male CD-1 mice (4–8 weeks old) were housed 4
per cage in a temperature controlled (68-72 F) room on
a 14:10 hour light/dark cycle (dark hours from 8 PM6 AM), and were given food and water ad libitum. Animal use protocols were approved by the Institutional
Animal Care and Use Committee of the University of
Kentucky.
Preparation of adult mouse spinal cord slices

Mice were anesthetized with 5% isoflurane and quickly
perfused transcardially with 10 ml of ice-cold sucrosecontaining artificial cerebrospinal fluid (aCSF) (sucroseaCSF) that contained (in mM): NaCl 95, KCl 1.8,
KH2PO4 1.2, CaCl2 0.5, MgSO4 7, NaHCO3 26, glucose
15, sucrose 50 kynurenic acid 1, oxygenated with 95%
O2, 5% CO2; pH 7.4. The lumbar spinal cord was rapidly
(within 90s) isolated by laminectomy from the cervical
enlargement to the cauda equina, placed in oxygenated
ice-cold sucrose-aCSF, cleaned of dura mater and ventral
roots, and super-glued vertically to a block of 4% agar
(Fisher Scientific, Pittsburgh, PA) on the stage of a
Campden 5000mz vibratome (Lafayette, IN). Transverse
slices (300–450 um) from lumbar segments L4-L5 were
cut in ice-cold sucrose-aCSF using minimum forward
speed ranging from 0.03 to 1 mm/s and using maximum
vibration. The ideal total dissection and slicing time to
insure slice viability was 22 minutes or less.
Fluorometric Ca2+ measurements

Slices were incubated for 60 min at room temperature
with Fura-2 AM (10 μM), pluronic acid (0.1%) in oxygenated aCSF containing (in mM): NaCl 127, KCl 1.8,
KH2PO4 1.2, CaCl2 2.4, MgSO4 1.3, NaHCO3 26, glucose
15, followed by a 20 min de-esterification period in normal aCSF. Prior to recording, slices were kept at RT in a
chamber containing approximately 150 ml of oxygenated
aCSF. In some studies, prior to incubation in fura-2,
slices were incubated for 20 min at 34 C in 1 μM SR101 in normal aCSF, as previously described [14].
Slices were perfused at 1–2 ml/min with normal aCSF
in an RC-25 recording chamber (Warner Instruments,
Hamden, CT) mounted on a Nikon FN-1 upright microscope fitted with a 79000 ET FURA2 Hybrid filter set
(Nikon Instruments, Melville, NY) and a Photometrics
CoolSNAP HQ2 camera (Tucson, AZ). Relative intracellular Ca2+ levels were determined by measuring the
change in ratio of fluorescence emission at 510 nm in
response to excitation at 340 and 380 nm (200 ms exposure). Paired images were collected at 1–1.5 seconds/
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frame. Relative changes in Ca2+ levels were evaluated
using Nikon Elements software by creating a region of
interest over the cell body and calculating the peak
change in ratio. The peak magnitude of Ca2+ transient
was expressed as difference in (ratio x 100) exposure to
exogenous glutamate compared to baseline before glutamate. The criteria for a Ca2+ response were considered
at least 10% increase above the baseline ratio. Ca2+ transients were in response to a 10 s exposure to 1 mM glutamate unless indicated otherwise. In antagonist studies,
the slice was perfused with the antagonist for 10 min
prior to and during glutamate stimulation. Only cells
that displayed a consistent control response to 1 mM
glutamate at the beginning and end of the experiment
(showing a less than 40% decrease in glutamate-evoked
Ca2+ transients) of were included in this study.
Electrophysiology

Cell-attached and/or whole-cell current-clamp recordings were obtained from dorsal horn neurons of the
spinal cord under visual guidance on an Olympus
BX51WI upright, fixed stage microscope equipped
with infrared differential interference contrast (IR-DIC)
and fluorescence optics (Olympus, Pittsburgh, PA). The
aCSF used for simultaneous Ca2+ imaging and electrophysiological recording consisted of (in mM): 124 NaCl,
3 KCl, 2 CaCl2, 1.3 MgCl2, 1.4 NaH2PO4, 26 NaHCO3,
and 11 glucose (pH 7.15–7.3); osmolality 290–
310 mOsm/kg. Recording pipettes with open resistance
of 2–5 MΩ were pulled from borosilicate glass capillaries with 0.45 mm wall thickness (King precision Glass,
Claremont, CA). Seal resistance was 1–5 GΩ and, for
whole-cell recordings, series resistance was 5–25 MΩ,
uncompensated. Patch pipettes were filled with (in mM):
130 K+-gluconate, 1 NaCl, 5 EGTA, 1 MgCl2, 1 CaCl2,
3 KOH, 4 ATP; pH = 7.2-7.4. Neural activity was
recorded using a Multiclamp 700B patch-clamp amplifier (Axon Instruments, Sunnyvale, CA), low-pass filtered at 5 kHz, acquired and with a Digidata 1440A
digitizer and pClamp 10.3 software. Action potentials
and whole-cell Na+ currents were analyzed off-line on a
PC-style computer with pCLAMP programs (Axon
Instruments) or Minianalysis 6.0.3 (Synaptosoft, Fort
Lee, NJ). For whole-cell recordings, APs were recorded
at rest in current-clamp mode. A 2-fold increase in firing
frequency was used as minimum threshold for responses
to glutamate stimulation.
For electrophysiology studies, chemical stimulation of
neurons in the dorsal horn was made by pressure applying L-glutamate (50 mM; 10–200 ms; dissolved in aCSF)
through a glass pipette (10 μm tip diameter) positioned at the surface of the slice (Picospritzer, ParkerHannefin, Fairfield, NJ, USA). Glutamate was applied
directly over the recoded cell to evoke unclamped, rapid
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APs and/or Ca2+ response. Slices were positioned such
that aCSF flowed dorsolaterally, away from the dorsal
horn to minimize possible direct effects of glutamate on
other neurons in the slice during recording.
Spared nerve injury (SNI) model

Mice were anesthetized with isoflurane (5% induction,
3% maintenance). The left hind-leg area was shaved and
wiped clean with alcohol and an incision was made in
the skin at the level of the trifurcation of the sciatic
nerve. The overlying muscles were retracted, exposing
the common peroneal, tibial, and sural nerves. Common
peroneal and tibial nerves were transected. Care was
taken to avoid touching or stretching the sural branch.
The muscle was sutured with absorbable 6–0 sutures
(Ethicon, Somerville, NJ) and the wound was closed with
9-mm metal clips. Sham surgery was produced by skin
incision at the level of the trifurcation, and by exposing
but not touching the sciatic branches.
Behavioral tests

Tactile threshold was assessed with an incremental series
of eight von Frey filaments of logarithmic stiffness
(Stoelting, Inc., Wood Dale, IL; approximately 0.008–
6.0 g). The 50% withdrawal threshold was determined
using Dixon’s up–down method, modified by Chaplan
et al. [79]. First, an intermediate von Frey hair (0.16 g)
was applied perpendicular to the hind-paw surface with
sufficient force to cause a slight bending of the filament.
In case of a positive response (rapid withdrawal of the
paw within 3 s), the next smaller filament was tested. In
case of a negative response, the next larger filament was
tested.
Chemicals

Fura-2 AM, Pluronic F-127 and Sulforhodamine 101
(SR-101) were purchased from Invitrogen (Carlsbad,
CA). Glutamate was purchased from Sigma (St. Louis,
MO). CNQX, GYKI 52466, AP-5, UBP-301, UBP-310
and AIDA were from Tocris Bioscience (Ellisville, MO).
Statistical Analysis

Outcomes were described for the experimental conditions using means ± SEM. For each glutamate-evoked response, a sample of cells was obtained from each slice
and was averaged as replicates. Data were analyzed using
GraphPad Prism 5 software (GraphPad Software, San
Diego, CA). One-way ANOVA (with repeated measures
where applicable) was used and Dunnett’s multiple comparison test was run (unless indicated otherwise) to determine significance compared to vehicle. For SNI vs.
sham experiments statistical tests were performed using
SAS v9.3 (Cary, NC). Slices were treated with different
concentrations. For each concentration and slice, the
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cells were treated as replicates and values for the cells
were averaged. A repeated measures ANOVA was implemented with experimental condition (SNI and sham) as
the between factor and concentration (0.03, 0.1, 0.3 and
1 mM) as the within factor. Pairwise comparisons were
implemented using Bonferonni adjustments.
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